[G24-37] Dupilumab (COPD) – 2nd Addendum to Project A24-79
Last updated 15.04.2025
Project no.:
G24-37
Commission:
Commission awarded on 10.12.2024 by the Federal Joint Committee (GBA).
Report type:
Addendum
Status:
Commission completed
Department/Division:
Health Economics
Topic:
Airways and respiratory system
Note:
If, in the course of the discussions on a commission of the GBA, a need for further revision arises, IQWiG submits an addendum. The GBA decides on the number of patients in the SHI target population.
The current version 1.1 of the addendum replaces version 1.0 published on Feb 20, 2025.
DOI:
https://doi.org/10.60584/G24-37_V1.1
| Project no. | Title | Status |
|---|---|---|
| A24-79 | Dupilumab (COPD) – Benefit assessment according to §35a Social Code Book V | Commission completed |
Federal Joint Committee (G-BA)
2025-02-20 A G-BA decision was published.